High-dose glucose-insulin-potassium treatment reduces myocardial apoptosis in patients with acute myocardial infarction

European Journal of Clinical Investigation

Volumn 35, Issue 3, 2005, Pages 164-170

  Zhang, L ^a,b,d   Li, Y H ^a   Zhang, H Y ^a   Chen, M L ^a   Gao, M M ^a   Hu, A H ^c   Yang, H S ^c   Liu, L S ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Sixth Hospital   (China)

^c FUWAI HOSPITAL   (China)

^d Sixth Hospital of Beijing City   (China)

Author keywords

Acute myocardial infarction; Apoptosis; Glucose insulin potassium; Reperfusion; sFas; sFas L

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GLUCOSE; INSULIN; POTASSIUM; STREPTAVIDIN;

ACUTE HEART INFARCTION; ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; INTRACORONARY INFUSION; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIGENS, CD95; APOPTOSIS; BIOLOGICAL MARKERS; CARDIOPLEGIC SOLUTIONS; COMBINED MODALITY THERAPY; FAS LIGAND PROTEIN; FEMALE; GLUCOSE; HUMANS; INSULIN; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; POTASSIUM; TROPONIN I;

EID: 20044384516     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2005.01468.x     Document Type: Article

References (27)

1. Diaz R, Paolasso EA, Piegas LS, Tajer CD, Moreno MG, Corvalan R et al. Metabolic Modulation of Acute Myocardial Infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 1998;98:2227-34.
2. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 1997;96:1152-6.
3. Stanley AW Jr, Moraski RE, Russell RO, Rogers WJ, Mantle JA, Kreisberg RA et al. Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease. Studies on myocardial carbohydrate, lipid and oxygen arterial-coronary sinus differences in patients with coronary artery disease. Am J Cardiol 1975;36:929-37.
4. Ceremuzynski L, Budaj A, Czepiel A, Burzykowski T, Achremczyk P, Smielak-Korombel W et al. Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction. Results a randomized multicenter Pol-GIK trial. Cardiovasc Drugs Ther 1999;13:191-200.
5. Jonassen AK, Brar BK, Mjos OD, Sack MN, Latchman DS, Yellon DM. Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism. J Mol Cell Cardiol 2000;32:757-64.
6. Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 2000;101:660-7.
7. Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and P70s6 kinase cell-survival signaling. Circ Res 2001;89:1191-8.
8. Gao F, Gao E, Yue TL, Ohlstein EH, Lopez BL, Christopher TA et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-Kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 2002;105:1497-502.
9. Orlinick JR, Vaishnaw AK, Elkon KB. Structure and function of Fas/Fas ligand. Int Rev Immunol 1999;18:293-308.
10. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S. Human Fas ligand. Gene structure, chromosomal location species specificity. Int Immunol 1994;6:1567-74.
11. Shimizu M, Fukuo K, Nagata S, Suhara T, Okuro M, Fujii K et al. Increased plasma levels of the soluble form of Fas ligand in patients with acute myocardial infarction and unstable angina pectoris. J Am Coll Cardiol 2002;39:585-90.
12. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): Effects on mortality at 1 year. J Am Coll Cardiol 1995;26:57-65.
13. van DHI, Zijlstra F, van't Hof AW, Doggen CJ, de Boer MJ, Suryapranata H et al. Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. J Am Coll Cardiol 2003;42:784-91.
14. McDaniel HG, Papapietro SE, Rogers WJ, Mantle JA, Smith LR, Russell RO Jr et al. Glucose-insulin-potassium induced alterations in individual plasma free fatty acids in patients with acute myocardial infarction. Am Heart J 1981;102:10-5.
15. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994;343:155-8.
16. Valori C, Thomas M, Shillingford J. Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction. Am J Cardiol 1967;20:605-17.
17. Opie LH. Cardiac metabolism in ischemic heart disease. Arch Mal Coeur Vaiss 1999;92:1755-60.
18. Svedjeholm R, Hakanson E, Szabo Z. Metabolic intervention for the ischemic and post-ischemic heart. Wien Klin Wochenschr 1999;111:501-11.
19. Cheng W, Kajstura J, Nitahara JA, Li B, Reiss K, Liu Y et al. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 1996;226:316-27.
20. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM. Apoptosis in human acute myocardial infarction. Circulation 1997;95:320-3.
21. Searle J, Kerr JF, Bishop CJ. Necrosis and apoptosis. Distinct modes cell death with fundamentally different significance. Pathol Annu 1982;17 Part 2:229-59.
22. Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T et al. Hypoxia induces apoptosis with enhanced expression of fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994;75:426-33.
23. Tanaka M, Suda T, Yatomi T, Nakamura N, Nagata S. Lethal effect of recombinant human Fas ligand in mice pretreated with propionibacterium acnes. J Immunol 1997;158:2303-9.
24. Suhara T, Fukuo K, Sugimoto T, Morimoto S, Nakahashi T, Hata S et al. Hydrogen peroxide induces up-regulation of fas in human endothelial cells. J Immunol 1998;160:4042-7.
25. Zhu MS, Liu DG, Cheng HQ, Xu XY, Li ZP. Expression of exogenous NF-IL6 induces apoptosis in Sp2/0-Ag14 myeloma cells. DNA Cell Biol 1997;16:127-35.
26. Petrucci MT, Ricciardi MR, Gregorj C, Ciapponi L, Savino R, Ciliberto G et al. Effects of IL-6 variants in multiple myeloma. Growth inhibition induction apoptosis primary cells. Leuk Lymphoma 2002;43:2369-75.
27. Oskeritzian CA, Zhao W, Pozez AL, Cohen NM, Grimes M, Schwartz LB. Neutralizing endogenous IL-6 renders mast cells of the MCT type from lung, but not the MCTC type from skin and lung, susceptible to human recombinant IL-4-induced apoptosis. J Immunol 2004;172:593-600.